Monday, April 18, 2016

BRIEF-Biotec Pharmacon Q1 EBITDA widens to loss NOK 3.5 mln

* Q1 revenue 17.3 million Norwegian crowns ($2.11

million)versus 12.3 million crowns year ago

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)